A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Clinical trial NCT04527380 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04527380
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-13
- Primary completion
- 2024-02-19
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.